جستجوی استاد راهنمای دانشگاهی

Dr. Inga Zeisset is a Senior Lecturer in the School of Applied Sciences at the University of Brighton, where she is part of the Ecology, Conservation and Society Research Excellence Group. Her work bridges molecular ecology with practical conservation applications, focusing particularly on amphibian species in Europe. Zeisset earned her BSc (Hons) in Ecology and Conservation with First Class honors from the University of Sussex (1994-1997), followed by a PhD in Molecular Ecology of North European Water Frogs from the same institution (1997-2001). Her doctoral research laid the foundation for her ongoing work in amphibian phylogeography and conservation genetics. Her research interests center on molecular ecology approaches to conservation challenges, with particular expertise in phylogeography, invasive species dynamics, the relationship between genetic diversity and fitness, adaptive genetic variation, and environmental DNA applications. Zeisset has developed specialized knowledge in amphibian conservation, particularly regarding pool frogs (Pelophylax lessonae) and their reintroduction to the UK. Her work frequently employs molecular methods including microsatellite analysis and MHC (Major Histocompatibility Complex) studies to address conservation questions. Analysis of her publication record shows a consistent research trajectory focused on amphibian conservation genetics, with recent work emphasizing practical conservation applications like species reintroduction monitoring and environmental DNA techniques. Her publications span molecular methodology development, phylogeographic studies, and applied conservation research, demonstrating how fundamental genetic research can inform conservation practice. The work shows increasing emphasis on practical conservation applications in recent years. Zeisset led the significant research project "Reintroduction of northern clade pool frogs (Pelophylax lessonae) to the UK" from 2014-2018, which represents a major contribution to amphibian conservation practice in Britain. Her supervisory interests include molecular ecology, amphibian ecology and conservation, phylogeography, species distribution, invasive species, and eDNA applications, indicating her commitment to training the next generation of conservation scientists. Her teaching philosophy emphasizes student-centered approaches, inquiry-based and cooperative learning. She incorporates practical sessions and group work into her lectures, providing guided reading and online resources to support deeper student engagement with course material outside the classroom.

• Molecular Ecology
• Amphibian Conservation
• Phylogeography
• +۵ مورد دیگر

Dr. Kathryn Stevens is an Honorary Clinical Senior Lecturer at the University of Glasgow, affiliated with the School of Cardiovascular & Metabolic Health and the Renal Department at Queen Elizabeth University Hospital. Her work focuses on nephrology, chronic kidney disease (CKD), renal transplantation, and cardiovascular comorbidities. She has contributed to over 30 peer-reviewed publications since 2009, addressing topics such as CKD biomarkers, health disparities, and translational research in kidney disease. Key Research Themes: CKD risk stratification, socioeconomic determinants of kidney disease, gender disparities in healthcare, and renal transplantation outcomes. Affiliations: Renal Department, Queen Elizabeth University Hospital; School of Cardiovascular & Metabolic Health. Her recent studies highlight controversies in CKD management (e.g., cystatin C vs. creatinine) and the impact of social deprivation on disease progression. She has also explored barriers to physical activity in CKD patients and gender inequities in kidney care. Collaborations span international networks, including work on global trends in renal transplantation and virtual conferencing innovations during the pandemic. No scientific awards or grants are explicitly listed in the provided text, but her active publication record underscores sustained research engagement. She has mentored colleagues on clinical practice guidelines for post-transplant care and contributed to textbook chapters on electrolyte and acid-base balance.

• Nephrology
• Chronic Kidney Disease (CKD)
• Renal Transplantation
• +۳ مورد دیگر

Dr. Simon Harris is a researcher affiliated with Newcastle University , contributing to diverse fields including Molecular Biology , Genetics , Microbiology , and Biomedical Sciences . His work spans evolutionary biology, genomic dynamics, and clinical studies, as evidenced by his publications. Research Interests: Harris's research focuses on topics such as bacterial secretion systems, reductive evolution in parasites, DNA methylation mechanisms, and phylogenetic methodologies. His studies also extend to clinical applications like liver fibrosis biomarkers and immunological disorders. Publications from 2002–2025 reveal expertise in microbial genetics, evolutionary theory, and biomedical research. Key themes include Molecular Evolution , Genomic Diversity , and Translational Medicine .

• Molecular Biology
• Genetics
• Microbiology
• +۳ مورد دیگر

Lara Graham is a Research Fellow at the University of Southampton specializing in cancer immunology with a focus on natural killer (NK) cell biology. Her work investigates NK cell mechanisms in anti-tumor immunity, particularly regarding hematological malignancies and solid tumors, through translational research targeting immune checkpoints and enhancing NK cell function for improved cancer therapies. Her research spans cancer immunology, NK cell biology, and immunotherapy, with emphasis on molecular mechanisms of NK cell activation via KIR receptors and the NKG2A:HLA-E checkpoint axis. She explores therapeutic strategies including XPO1 inhibition to sensitize cancer cells to NK-mediated killing and develops antibody-based approaches to overcome tumor immune evasion, contributing significantly to immuno-oncology advancements. Analysis of her 2022-2024 publications reveals a strong translational focus, with key themes including CAR-NK engineering, antibody-dependent cellular cytotoxicity enhancement, and disruption of immune checkpoints. Her work demonstrates consistent innovation in leveraging NK cell biology for clinical applications, particularly in chronic lymphocytic leukemia and solid tumor contexts. No scientific awards were documented in the provided materials. While no explicit details about student advising or research grants were available, her collaborative publication pattern suggests active mentorship within research teams focused on immunotherapy development. Graham operates within interdisciplinary research networks at the University of Southampton, collaborating extensively with immunologists, oncologists, and hematologists including Matthew D. Blunt and Salim I. Khakoo. Her work appears anchored in translational cancer research teams investigating NK cell-based therapies, particularly for hematological malignancies and immune checkpoint modulation.

• Cancer Immunology
• Natural Killer Cell Biology
• Immunotherapy
• +۳ مورد دیگر

Professor Tim Aitman serves as Chair of Molecular Pathology and Genetics and Director of the Centre for Genomic and Experimental Medicine within the University of Edinburgh’s Institute of Genetics and Cancer, holding an Honorary Consultant Physician position with NHS Lothian. He leads the Scottish Genomes Partnership and founded the One Health Genomics Edinburgh network with over 600 researchers. His affiliations extend to the CRUK Edinburgh Centre and BioCaptiva, a spinout company developing cell-free DNA capture technology. His research integrates classical genetics with cutting-edge genomic technologies to investigate rare and common human disorders. Key focus areas include: Genetic basis of insulin resistance syndromes and autoimmune diseases like systemic lupus Next-generation sequencing for rare disease diagnosis (familial hypercholesterolemia, Ehlers-Danlos, nephrotic syndrome) Liquid biopsy development for cancer stratification using cell-free DNA analysis Evolutionary genomics through rat genome sequencing projects His work has pioneered methods for identifying complex trait genes and demonstrated copy number variation’s role in immune diseases. Professor Aitman’s publication portfolio shows strong emphasis on translational genomics, with recent articles focusing on liquid biopsy applications in prostate cancer radiotherapy, acute aortic syndromes, and oropharyngeal cancer. His research consistently bridges basic genomic discovery with clinical implementation, particularly in cancer diagnostics and rare disease genomics. His scientific recognition includes: Fellowship in the Royal Colleges of Physicians of London and Edinburgh Fellowship in the Academy of Medical Sciences Senior Fellowship at the PHG Foundation Specialist Adviser for the House of Lords Science and Technology Committee As principal investigator, he has secured over £30 million in research funding from major bodies including MRC, ERC, CRUK, and AstraZeneca. His leadership extends to the BioCaptiva spinout (£3M+ investment) and the University of Edinburgh’s COVID-19 testing program (TestEd). Current projects focus on cell-free DNA biomarkers for radiotherapy adaptation and acute disease monitoring. He directs the Centre for Genomic and Experimental Medicine at Edinburgh’s Western General Hospital campus, fostering collaborations across the Institute of Genetics and Cancer. His One Health Genomics network integrates veterinary and human genomic research, while partnerships with CRUK Edinburgh Centre and NHS Lothian drive clinical translation of genomic technologies.

• Genetics
• Genomics
• Epigenetics
• +۵ مورد دیگر

Dr Francesco Colucci is a researcher in the Department of Obstetrics & Gynaecology at the University of Cambridge Clinical School . His work focuses on the role of maternal immune cells, particularly uterine natural killer (NK) cells, in regulating placental development and fetal growth. By studying interactions between maternal MHC class I molecules and NK cell receptors, he aims to decode the immunological mechanisms underlying pregnancy outcomes and disease predispositions. Specialties: Immunology, Genetics, Reproductive Health, Obstetrics, Pathology His research explores how immune signals at the maternal-fetal interface influence vascular remodeling, placental biology, and long-term health programming of offspring. Recent work highlights the role of KIR-NKG2A receptors and ATP-sensitive potassium channels in NK cell development and function. Selected publications reveal trends in reproductive immunogenetics, fetal-maternal tolerance, cancer-immunology parallels, and technological advancements via microfluidic devices for embryo culture studies. Collaborations span immunology, fetal medicine, and oncology disciplines.

• Immunology
• Genetics
• Reproductive Health
• +۶ مورد دیگر

Guy Jacobs is a Research Fellow at the University of Cambridge, Department of Archaeology, specializing in evolutionary genetics and microbiome ecology. His work combines large-scale genomic datasets with computational modeling to investigate human evolutionary history, archaic hominin interactions, and microbiome dynamics during subsistence transitions in traditionally hunter-gatherer communities across India and Indonesia. Primary focus on population genetics, human adaptation, and social network impacts Expertise in computational modeling of evolutionary processes Collaborations with C-CLEAR DTP and CREATES partnerships Research spans ancient DNA analysis, archaic introgression patterns, and the interplay between genetic ancestry, environment, and health outcomes. Key projects include studies of Denisovan ancestry in Island Southeast Asia, microbiome differentiation in lifestyle transitions, and sociocultural influences on genetic diversity. Recent publications highlight trends in human adaptation to malaria and high-altitude environments, microbiome evolution during urbanization, and computational methods for detecting selective sweeps. His work integrates genomic data with social and environmental variables to address questions in biological diversity and human phenotypic variation. As part of the Cambridge NERC Doctoral Landscape Awards, he supervises students on topics ranging from archaic introgression analysis to genetic disease mapping. He utilizes datasets from Indonesia, India, and the Indonesian archipelago, combining genetic, transcriptomic, and mobility data in his research.

• Evolutionary genetics
• Population genetics
• Human evolutionary biology
• +۱۲ مورد دیگر

Professor David van Heel is a Professor of Genetics at Queen Mary University of London and an Honorary Consultant Physician at Barts Health NHS Trust. His research focuses on genomic medicine, particularly in British Bangladeshi and Pakistani communities, leveraging genetics and NHS health data. He leads the Genes & Health study, a longitudinal cohort of 60,000 volunteers, advancing clinical and genetic insights in underserved populations. His work on human knockouts and rare genetic variants has been transformative, including seminal studies in Science and Nature . Previously, he pioneered genetic research in celiac disease, identifying key immune-related genetic markers. He holds leadership roles at the Blizard Institute, served on the MRC Population and Systems Medicine Board (2016–2022), and was Deputy Chief Clinical Information Officer at Barts Health NHS Trust (2013–2024). His research bridges clinical practice and population health, addressing complex genetic and autoimmune disorders. Education: Trained in clinical research through MRC and Wellcome Trust fellowships. Research interests include genomic studies of ethnic minorities, autoimmune disease genetics, and translational medicine. Key contributions include over 10 high-impact papers in Nature , Nature Genetics , and Science , and the development of novel therapeutic approaches via genetic insights. His work on celiac disease epitopes led to clinical trials of immunotherapeutics. Ongoing projects emphasize precision medicine and population health equity.

• Genomic Medicine
• Medical Genetics
• Immunology
• +۳ مورد دیگر

Clett Erridge is a Senior Lecturer in Immunology at Anglia Ruskin University (ARU), affiliated with the Medical Technology Research Centre, School of Life Sciences, and Faculty of Science and Engineering. His research focuses on molecular mechanisms linking inflammation to lipid metabolism, particularly in coronary artery disease, and novel approaches to enhance macrophage phagocytosis of tumor cells. He holds a BSc (Molecular Biology, 1997) and PhD (Molecular Immunology, 2003) from the University of Edinburgh. Postdoctoral research at Strathclyde and Leicester Universities explored oxidised lipids' impact on innate immunity and lipid metabolism. Current work addresses innate immune signaling in metabolic disease and cancer immunotherapy. Research interests include: mechanisms connecting pattern-recognition receptors to lipid metabolism; microbiota-derived regulators of immunity; and therapeutic strategies to boost macrophage-mediated tumor cell clearance. He supervises PhD students in macrophage lipid metabolism, atherosclerosis, and cancer immunotherapy drug development. Teaching responsibilities include MSc Laboratory Techniques module leadership, and contributions to courses like Clinical Immunology and Metabolism and its Control. Major grants include a £123,000 Oncobiopharm-sponsored study (2018-19) on therapeutic antibodies targeting annexin pathways, and a £54,000 Iraq-funded PhD studentship (2013-2016) on diet's role in atherosclerosis. Over £1M in research funding secured across 12 grants since 2003. Awarded Fellow of the Higher Education Academy and serves as Associate Editor for Frontiers in Immunology . Active in professional societies including the British Atherosclerosis Society and British Society for Cardiovascular Research. Key publications from 2003-2020 explore TLR signaling in atherosclerosis, dietary endotoxins' inflammatory effects, and macrophage foam cell formation mechanisms. Media engagements include BBC Radio Cambridgeshire and Medicalresearch.com interviews.

• Cell and Molecular Biology
• Life Sciences
• Innate Immune Signaling
• +۵ مورد دیگر

Dr. May Sin Ke is a Junior Research Fellow and Postdoctoral Researcher in the Department of Oncology at the University of Oxford's Old Road Campus. Her research focuses on immunotherapy in cancer, particularly leveraging bispecific monoclonal antibodies for colorectal cancer and adenocarcinomas. She specializes in developing biological assays to model cancer biology and identify therapeutic targets. Her doctoral work at Oxford explored tumour heterogeneity in triple-negative breast cancer under hypoxic conditions using single-cell sequencing. During her BSc at the University of Tsukuba, Japan, she developed 3D spheroid models of dermal papilla cells for hair growth screening. Key research interests include tumour heterogeneity, hypoxia-driven cancer mechanisms, and translational applications of 3D cell culture models. Her recent publications emphasize single-cell technologies and their challenges in understanding cellular diversity in oncology. No scientific awards are listed in the provided text. Her work contributes to therapeutic target discovery through advanced cellular and molecular approaches.

• Immunotherapy
• Cancer Biology
• Immunogenetics
• +۳ مورد دیگر

John McLauchlan is Professor of Viral Hepatitis at the University of Glasgow’s Centre for Virus Research within the School of Infection & Immunity. He leads the McLauchlan Group, which investigates virus-host interactions, RNA virus evolution, and transmission dynamics, focusing on hepatitis C virus (HCV) and dengue virus (DENV). His research addresses four key areas: host factors limiting HCV replication, HCV strain responses to direct-acting antivirals, UK transmission hubs through HCV Research UK, and high-throughput sequencing diagnostics for DENV. McLauchlan’s research integrates virology, immunology, and epidemiology to study viral persistence and pathogenesis. His work on HCV explores mechanisms of chronic infection leading to liver disease, while DENV research focuses on biomarker discovery for severe disease prediction. Collaborative projects span multiple institutions including the University of Bristol, Queens’ University Belfast, and international partners in the Philippines and China. Recent publications (2019-2023) demonstrate strong focus on antiviral resistance mechanisms, interferon signaling pathways, viral genomics, and real-world treatment outcomes. Research consistently employs cutting-edge genomic techniques and bioinformatics tools like GLUE for viral sequence analysis. McLauchlan currently advises PhD student Majo Galarion and maintains collaborations with Dr. Ana Filipe (CVR), Prof. Emma Thomson, and international researchers. He established HCV Research UK, a national clinical database and biobank funded by the Medical Research Foundation. The group operates within the MRC-University of Glasgow Centre for Virus Research infrastructure.

• Virology
• Virus-Host Interactions
• RNA Virus Evolution
• +۷ مورد دیگر

Dr. David Miller is a Senior Lecturer in Biological Chemistry and Director of Postgraduate Taught (PGT) Programmes at the School of Chemistry, Cardiff University. With over two decades of academic experience, he leads research at the intersection of synthetic organic chemistry and biological systems, focusing on enzyme mechanisms and applications in drug discovery. MA in Chemistry with Supplementary Quantum Chemistry, Oriel College Oxford (1989-1993) PhD, Southampton University under Prof. T. D. H. Bugg (1993-1997) Dr. Miller's research centers on applying synthetic organic chemistry to solve biological problems and vice versa. His work explores how small organic molecules can probe the function of biological macromolecules like proteins and DNA. His primary research areas include: Inositol monophosphatase : Studying this enzyme's mechanism as a target for bipolar disorder treatments mu-Calpain research : Developing inhibitors for autoimmune diseases like rheumatoid arthritis and osteoarthritis Terpenoid biosynthesis : Investigating how terpene cyclases generate diverse natural products from common precursors Analysis of Dr. Miller's recent publications reveals a strong focus on enzyme engineering, particularly with terpene synthases. His work combines computational modeling, structural biology, and synthetic chemistry to manipulate enzyme function. A significant trend is the exploration of enzyme plasticity to create novel catalytic activities and non-natural products. His research bridges fundamental enzymology with practical applications in drug discovery and biocatalysis. Dr. Miller is a Member of the Royal Society of Chemistry (MRSC), reflecting his contributions to the field of chemical sciences. As Director of Postgraduate Taught Programmes, Dr. Miller oversees curriculum development and student supervision. He teaches across multiple levels, from foundational organic chemistry to specialized courses in biocatalysis and drug development. His research group receives funding for projects exploring enzyme mechanisms and their applications in therapeutic development. Dr. Miller's laboratory focuses on the structural and mechanistic aspects of enzyme catalysis, with particular emphasis on terpene synthases and calpain proteases. His team combines synthetic organic chemistry, protein engineering, and structural biology approaches to unravel complex biochemical processes.

• Synthetic Organic Chemistry
• Biological Chemistry
• Enzymology
• +۵ مورد دیگر

Dr. Maria Antonietta Nettis is a Clinical Research Fellow and Consultant Psychiatrist at King's College London (KCL) and South London and Maudsley NHS Trust. She holds an affiliation with the School of Academic Psychiatry and the Department of Psychological Medicine. Her academic journey includes completing a full-time PhD (2021) in KCL's Stress Psychiatry and Immunology Lab, focusing on immune system roles in depression. She is also a core member of the Stress Psychiatry and Immunology Group. Her clinical training was completed in Italy (2017), complementing her academic roles. Teaching responsibilities include lectures on Therapeutic Research, Women’s Mental Health, and Biological Psychiatry modules for MSc programs at KCL, alongside supervising master’s students since 2019. Nettis’ research interests center on immunopsychiatry, neuroinflammation, and gender disparities in mental health. Her work bridges clinical practice and research, with notable contributions to studies on minocycline’s antidepressant effects, TSPO PET imaging in depression, and sex hormone dysregulation in inflammatory depression. She actively engages in public dissemination via platforms like InSPIreTheMind , authoring blogs and hosting podcasts on topics including women in STEM and neuroinflammation. Her interdisciplinary approach integrates psychiatry, immunology, and neuroscience to address complex mental health challenges.

• Immunopsychiatry
• Interface between physical and mental health
• Women's mental health
• +۳ مورد دیگر

Professor Chris Day is a leading academic at Newcastle University , with a focus on liver diseases, particularly non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease. His research spans genetics, biomarker discovery, and lifestyle interventions, often involving international collaborations. Affiliation: Newcastle University Academic Rank: Professor Research Interests: Professor Day investigates the genetic and environmental factors driving liver disease progression, including inflammation, fibrosis, and cardiometabolic complications. His work emphasizes the role of polymorphisms (e.g., PNPLA3, TM6SF2), non-invasive diagnostic tools (e.g., FibroTest), and interventions like exercise and dietary modifications. Recent Article Trends: His recent publications analyze genetic risk scores for cirrhosis, lipid metabolism in inflammation, and the impact of aging on fibrosis diagnosis. These studies highlight cross-disciplinary themes in genomics, metabolomics, and clinical epidemiology. Scientific Contributions: Key contributions include validating biomarkers for liver fibrosis, exploring the gut-liver axis in type 2 diabetes, and leading clinical trials on antifibrotic therapies (e.g., losartan). His work bridges translational research and public health applications.

• Hepatology
• Non-Alcoholic Fatty Liver Disease (NAFLD)
• Alcoholic Liver Disease
• +۷ مورد دیگر

Dr. Chenyu Zhao is a Senior Research Fellow at the University of Plymouth's School of Engineering, Computing and Mathematics. His research focuses on Marine Renewable Energy, particularly offshore wind farms, wave energy conversion, and marine autonomous robotic intervention systems. He previously served as a Research Fellow at the University of Exeter and holds a PhD in Marine Engineering from Ocean University of China. Dr. Zhao's research interests encompass renewable energy technologies, hydrodynamic modeling, and advanced marine structures. His work contributes to sustainable energy solutions through innovations in wave energy converter design and offshore system optimization. His recent publications demonstrate interdisciplinary research spanning marine engineering, renewable energy systems, biomedical applications of marine materials, and computational modeling techniques. This reflects a consistent focus on solving complex problems through integrated engineering approaches.

• Marine Renewable Energy
• Offshore Wind Farms
• Wave Energy
• +۲ مورد دیگر